20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .): Difference between revisions
Wikipatents (talk | contribs) Automated patent report |
Wikipatents (talk | contribs) Automated patent report |
||
| Line 19: | Line 19: | ||
<!-- JSON-LD markup for search engines: | <!-- JSON-LD markup for search engines: | ||
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)","name":"20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)","description":"Patent application abstract and classification for 20250177581 - Ntsr1-targeted Rad","datePublished":"2025-06- | {"@context":"https://schema.org","@type":"TechArticle","headline":"20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)","name":"20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)","description":"Patent application abstract and classification for 20250177581 - Ntsr1-targeted Rad","datePublished":"2025-06-11","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177581","name":"Ntsr1-targeted Rad","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Fusion Pharmaceuticals Inc."}]}} | ||
--> | --> | ||
Latest revision as of 03:44, 11 June 2025
NTSR1-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY
Abstract: methods for treating or ameliorating cancer comprising administering to a mammal a ntsr-1 targeted radiopharmaceutical comprising a radionuclide chelated to a compound of formula i, and dna damage response inhibitors.
Inventor(s): John R. Forbes, Saleemulla Mahammad
CPC Classification: A61K51/0497 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250177581